APPLICATION OF SERUM AMYLOID A GENE FOR DIAGNOSIS AND THERAPY OF GLAUCOMA AND IDENTIFICATION OF ANTIGLAUCOMATOUS AGENT Russian patent published in 2012 - IPC A61K31/395 

FIELD: medicine.

SUBSTANCE: group of inventions refers to diagnosis and therapy of glaucoma and represents compositions and methods of treating glaucoma, diagnostic technique for glaucoma and methods for identifying agents which may be applicable for treating glaucoma. More specifically, the present group of inventions describes applying the agents which modulate serum amyloid A expression.

EFFECT: given inventions ensure effective diagnosis and therapy of ocular hypertension.

9 cl, 14 dwg, 4 tbl, 7 ex